| Missing heritability of common diseases and treatments outside the protein-coding exome W Sadee, K Hartmann, M Seweryn, M Pietrzak, SK Handelman, ... Human genetics 133, 1199-1215, 2014 | 84 | 2014 |
| AmpliSeq transcriptome analysis of human alveolar and monocyte-derived macrophages over time in response to Mycobacterium tuberculosis infection AC Papp, AK Azad, M Pietrzak, A Williams, SK Handelman, RP Igo Jr, ... PloS one 13 (5), e0198221, 2018 | 47 | 2018 |
| Statin pharmacogenomics: pursuing biomarkers for predicting clinical outcomes JP Kitzmiller, PF Binkley, SR Pandey, AM Suhy, D Baldassarre, ... Discovery medicine 16 (86), 45, 2013 | 36 | 2013 |
| The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations ES Barrie, K Hartmann, SH Lee, JT Frater, M Seweryn, D Wang, W Sadee Human Mutation 38 (1), 112-119, 2017 | 29 | 2017 |
| Primary care continuity improves diabetic health outcomes: from free clinics to federally qualified health centers PP Mehta, JE Santiago-Torres, CE Wisely, K Hartmann, FA Makadia, ... The Journal of the American Board of Family Medicine 29 (3), 318-324, 2016 | 23 | 2016 |
| Interactions Between Regulatory Variants in CYP7A1 (Cholesterol 7α-Hydroxylase) Promoter and Enhancer Regions Regulate CYP7A1 Expression D Wang, K Hartmann, M Seweryn, W Sadee Circulation: Genomic and Precision Medicine 11 (10), e002082, 2018 | 21 | 2018 |
| Regulation of cholesteryl ester transfer protein expression by upstream polymorphisms: reduced expression associated with rs247616 A Suhy, K Hartmann, AC Papp, D Wang, W Sadee Pharmacogenetics and genomics 25 (8), 394-401, 2015 | 18 | 2015 |
| Erratum to: Non-linear interactions between candidate genes of myocardial infarction revealed in mRNA expression profiles K Hartmann, M Seweryn, SK Handelman, GA Rempała, W Sadee BMC genomics 17 (1), 988, 2016 | 17* | 2016 |
| Non-linear interactions between candidate genes of myocardial infarction revealed in mRNA expression profiles K Hartmann, M Seweryn, SK Handleman, GA Rempała, W Sadee BMC genomics 17 (1), 1-14, 2016 | 17 | 2016 |
| Pharmacogenomics: Driving personalized medicine W Sadee, D Wang, K Hartmann, AE Toland Pharmacological Reviews 75 (4), 789-814, 2023 | 16 | 2023 |
| Genetic variants affecting alternative splicing of human cholesteryl ester transfer protein A Suhy, K Hartmann, L Newman, A Papp, T Toneff, V Hook, W Sadee Biochemical and biophysical research communications 443 (4), 1270-1274, 2014 | 16 | 2014 |
| Analyzing allele specific RNA expression using mixture models R Lu, RM Smith, M Seweryn, D Wang, K Hartmann, A Webb, W Sadee, ... BMC genomics 16 (1), 1-11, 2015 | 12 | 2015 |
| Interpreting coronary artery disease GWAS results: A functional genomics approach assessing biological significance K Hartmann, M Seweryn, W Sadee PloS one 17 (2), e0244904, 2022 | 6 | 2022 |
| A transatlantic perspective on the integration of immuno-oncology prognostic and predictive biomarkers in innovative clinical trial design M Morfouace, SM Hewitt, R Salgado, K Hartmann, S Litiere, S Tejpar, ... Seminars in cancer biology 52, 158-165, 2018 | 5 | 2018 |
| Imaging genomics: data fusion in uncovering disease heritability K Hartmann, CY Sadée, I Satwah, F Carrillo-Perez, O Gevaert Trends in Molecular Medicine 29 (2), 141-151, 2023 | 3 | 2023 |
| Conditional entropy in variation-adjusted windows detects selection signatures associated with expression quantitative trait loci (eQTLs) SK Handelman, M Seweryn, RM Smith, K Hartmann, D Wang, M Pietrzak, ... BMC genomics 16 (8), 1-8, 2015 | 2 | 2015 |
| 68Ga-DOTATATE PET to Characterize Lesions in the Neuroaxis K Hartmann, JA Gillman, JW Lazor, JB Ware, JK Weeks, IM Nasrallah, ... Clinical Nuclear Medicine, 10.1097, 2022 | | 2022 |
| 146 Successful identification of copy number variations using next generation sequencing with a tumour panel in plaque/tumour mycosis fungoides J Yoo, M Morfouace, K Hartmann, J Cazier, B Noyvert, A Beggs, P Moss, ... Journal of Investigative Dermatology 138 (5), S25, 2018 | | 2018 |
| From bench to clinical trials the EORTC experience in biology-based clinical cancer research K Tryfonidis, K Hartmann, M Morfouace, D Lacombe Journal of the Egyptian National Cancer Institute 29 (4), 171-176, 2017 | | 2017 |
| Addressing the Missing Heritability of Coronary Artery Disease KLS Hartmann The Ohio State University, 2016 | | 2016 |
Wolfgang SadeeProfessor of Medicine and PharmacologyVerified email at osumc.edu
